| Preface to the Paperback Edition |
|
ix | |
| Introduction: Drugs Are Different |
|
xix | |
|
1. The $200 Billion Colossus |
|
|
3 | (18) |
|
2. The Creation of a New Drug |
|
|
21 | (16) |
|
3. How Much Does the Pharmaceutical Industry Really Spend on R & D? |
|
|
37 | (15) |
|
4. Just How Innovative Is This Industry? |
|
|
52 | (22) |
|
5. "Me-Too" Drugs-The Main Business of the Pharmaceutical Industry |
|
|
74 | (20) |
|
6. How Good Are New Drugs? |
|
|
94 | (21) |
|
7. The Hard Sell...Lures, Bribes, and Kickbacks |
|
|
115 | (20) |
|
8. Marketing Masquerading as Education |
|
|
135 | (21) |
|
9. Marketing Masquerading as Research |
|
|
156 | (17) |
| 10. Patent Games-Stretching Out Monopolies |
|
173 | (20) |
| 11. Buying Influence-How the Industry Makes Sure It Gets Its Way |
|
193 | (24) |
| 12. Is the Party Over? |
|
217 | (20) |
| 13. How to Save the Pharmaceutical Industry-And Get Our Money's Worth |
|
237 | (24) |
| Afterword |
|
261 | (4) |
| Epilogue: The Saga of Vioxx and the COX-2 Inhibitors |
|
265 | (12) |
| Acknowledgments |
|
277 | (2) |
| Notes |
|
279 | (26) |
| Index |
|
305 | |
Shopping Cart
